Impact of Baseline Covariates on the Immunogenicity of a Quadrivalent (Types 6, 11, 16, and 18) Human Papillomavirus Virus‐Like‐Particle Vaccine
Open Access
- 15 October 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (8) , 1153-1162
- https://doi.org/10.1086/521679
Abstract
Background.The quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-like-particle vaccine was 95%–100% effective in preventingKeywords
This publication has 0 references indexed in Scilit: